Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.

MLA

Martin, Peter R., et al. “Magnetic Resonance Imaging-Targeted, 3D Transrectal Ultrasound-Guided Fusion Biopsy for Prostate Cancer: Quantifying the Impact of Needle Delivery Error on Diagnosis.” Medical Physics, vol. 41, no. 7, July 2014, p. 1–N.PAG. EBSCOhost, https://doi.org/10.1118/1.4883838.

APA

Martin, P. R., Cool, D. W., Romagnoli, C., Fenster, A., & Ward, A. D. (2014). Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis. Medical Physics, 41(7), 1–N.PAG. https://doi.org/10.1118/1.4883838

Chicago

Martin, Peter R., Derek W. Cool, Cesare Romagnoli, Aaron Fenster, and Aaron D. Ward. 2014. “Magnetic Resonance Imaging-Targeted, 3D Transrectal Ultrasound-Guided Fusion Biopsy for Prostate Cancer: Quantifying the Impact of Needle Delivery Error on Diagnosis.” Medical Physics 41 (7): 1–N.PAG. doi:10.1118/1.4883838.